For more information please call:
1.877.CRIVER.1 (1.877.274.8371)askcharlesriver@crl.com
*indicates a required field.
The information you provided will be kept confidential.
Mar 17–Mar 20
Stop by Charles River booth 105 at the 2010 American Society for Clinical Pharmacology and Therapeutics Annual Meeting to find out how we offer you more to accelerate your drug development program.
May 05–May 05
Charles River will host a seminar that will focus on best practices and available resources to help manage rodent animal colonies and preserve the integrity of valuable research. Discussions with the presenters will enhance understanding of the material.
The Corporate Senior VP of Corporate Development is responsible for directing the global corporate development function, which includes an active merger and acquisition practice; evaluating, identifying and pursuing a wide variety of strategic business opportunities, mergers and acquisitions that are compatible with the company's long-term goals; leading and participating in the development of joint ventures, market opportunities, mergers/acquisitions and monitoring technology developments; assisting with the development of long-range global strategic plans for the company by working with the Senior VP of Corporate Strategy.
This position is responsible for overseeing the worldwide tax provision process; implementing software solution for non-US tax provisions; reviewing non-US income tax returns; coordinating company’s non-US entities to ensure current tax planning strategies are properly documented; coordinating the preparation of US tax returns with outside advisors to ensure accurate and timely filings; calculating company’s effective tax rate on a quarterly and annual basis; preparing FAS 109 work papers; ensuring that tax accounts within the general ledger are maintained properly; responding to federal, state and local income tax notices and managing tax examinations; recommending corporate tax reduction strategies; and managing the sales and use tax compliance process.
Charles River Laboratories, Inc.